Polina Kryukova

Mrs. Polina Kryukova

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2023 in Genes
Verified
Journal Article
Open access
PDF file
EPElena A. Ponomarenko
Elena A. Ponomarenko
GKGeorge S. Krasnov
George S. Krasnov
OKOlga Kiseleva
Olga Kiseleva
PKPolina Kryukova
Polina Kryukova
VAViktoriia Armenovna Arzumanian
Viktoriia Armenovna Arzumanian
EPEkaterina Poverennaya
Ekaterina Poverennaya
Transcriptomics methods (RNA-Seq, PCR) today are more routine and reproducible than proteomics methods, i.e., both mass spectrometry and immunochemical analysis. For this reason, most scientific studies are limited to assessing the level of mRNA content. At the same time, protein content (and its post-translational status) largely determines the cell’s state and behavior. Such a forced extrapolation of conclusions from the transcriptome to the proteome often seems unjustified. The ratios of “transcript-protein” pairs can vary by several orders of magnitude for different genes. As a rule, the correlation coefficient between transcriptome–proteome levels for different tissues does not exceed 0.3–0.5. Several characteristics determine the ratio between the content of mRNA and protein: among them, the rate of movement of the ribosome along the mRNA and the number of free ribosomes in the cell, the availability of tRNA, the secondary structure, and the localization of the transcript. The technical features of the experimental methods also significantly influence the levels of the transcript and protein of the corresponding gene on the outcome of the comparison. Given the above biological features and the performance of experimental and bioinformatic approaches, one may develop various models to predict proteomic profiles based on transcriptomic data. This review is devoted to the ability of RNA sequencing methods for protein abundance prediction.

Verified
Journal Article
Open access
PDF file
OKOlga Kiseleva
Olga Kiseleva
VAViktoriia Armenovna Arzumanian
Viktoriia Armenovna Arzumanian
YIYuriy Andreevich Ikhalaynen
Yuriy Andreevich Ikhalaynen
Ilia Yurievich KurbatovIlia Yurievich Kurbatov
Ilia Yurievich Kurbatov
PKPolina Kryukova
Polina Kryukova
EPEkaterina Poverennaya
Ekaterina Poverennaya
Despite their astonishing biological diversity, surprisingly few shared traits connect all or nearly all living organisms. Aging, i.e., the progressive and irreversible decline in the function of multiple cells and tissues, is one of these fundamental features of all organisms, ranging from single-cell creatures to complex animals, alongside variability, adaptation, growth, healing, reproducibility, mobility, and, finally, death. Age is a key determinant for many pathologies, shaping the risks of incidence, severity, and treatment outcomes for cancer, neurodegeneration, heart failure, sarcopenia, atherosclerosis, osteoporosis, and many other diseases. In this review, we aim to systematically investigate the age-related features of the development of several diseases through the lens of multiomics: from genome instability and somatic mutations to pathway alterations and dysregulated metabolism.

Verified
Journal Article
Open access
PDF file
OKOlga Kiseleva
Olga Kiseleva
YIYuriy Andreevich Ikhalaynen
Yuriy Andreevich Ikhalaynen
Ilia Yurievich KurbatovIlia Yurievich Kurbatov
Ilia Yurievich Kurbatov
VAViktoriia Armenovna Arzumanian
Viktoriia Armenovna Arzumanian
PKPolina Kryukova
Polina Kryukova
EPEkaterina Poverennaya
Ekaterina Poverennaya
The analysis of biological fluids plays a crucial role in biomarker discovery, disease diagnostics, and precision medicine. Dried sample carriers—such as dried blood spots, dried plasma, serum, saliva, tears, and urine—have emerged as powerful tools, offering advantages in sample collection, storage, and transport, particularly in remote and resource-limited settings. Recent advances in proteomic methodologies have expanded the potential of these dried matrices, yet challenges related to protein stability, sensitivity, and standardization persist. This review critically examines the current state of proteomic investigations using dried biological fluids. Furthermore, we compare proteomics’ progress in this field with other omics approaches, such as metabolomics, to contextualize its development and integration potential. While dried fluid proteomics is promising for non-invasive diagnostics and large-scale epidemiological studies, addressing technical limitations will be essential for its broader adoption in clinical and translational research.